Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis

Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension

(2014) Oliver Dörr et al.   Clinical Research in Cardiology

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

(2014) D. E. Kandzari et al.   EUROPEAN HEART JOURNAL

Soluble fms-Like Tyrosine Kinase-1 and Endothelial Adhesion Molecules (Intercellular Cell Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1) as Predictive Markers for Blood Pressure Reduction After Renal Sympathetic Denervation

(2014) Oliver Dörr et al.   HYPERTENSION

A Controlled Trial of Renal Denervation for Resistant Hypertension

(2014) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension

(2012) Mathias C. Brandt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

(2010)   LANCET

Heart Disease and Stroke Statistics—2009 Update

(2009) et al.   CIRCULATION

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover

(2009) Ramón Martos et al.   EUROPEAN JOURNAL OF HEART FAILURE

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

(2009) Henry Krum et al.   LANCET

Biochemical markers of myocardial remodelling in hypertensive heart disease

(2008) A. Gonzalez et al.   CARDIOVASCULAR RESEARCH

Resistant Hypertension: Diagnosis, Evaluation, and Treatment

(2008) David A. Calhoun et al.   CIRCULATION

Cellular and molecular mechanisms of fibrosis

(2007) TA Wynn   JOURNAL OF PATHOLOGY